Synthesized Non-Hallucinogenic LSD Puts BetterLife Pharma on Psychedelic Investors Radar Nov 18, 2021
InMed Pharmaceuticals Sees Historic Volume As It Enters Commercial Stage Of Bulk Cannabinoid Sales Nov 18, 2021
PharmaDrug Provides Research Results and Initiates IND-Enabling Studies for Cepharanthine in the Treatment of Multiple… Nov 18, 2021
UCSF Releases Positive Report On Bucillamine’s Ability To Disrupt The Delta Variant And Protect Lungs In Vivo Nov 17, 2021
CEOs Kelsey Ramsden and Anthony Tennyson Talk Psychedelic Partnerships: “Further, Faster, Together” Nov 16, 2021
